The Digital Pathology Market size was estimated at $685.43 billion in 2020, growing at a CAGR of 8.2% during the forecast period 2021-2026. Digital pathology encompasses the collecting, management, exchange, and interpretation of pathology data, including slides and data, in a digital setting. Scanning is used to capture digital pathology images, and robotic microscopy can be used to get whole slide imaging / virtual microscopy on an entire histological (microscopic) glass slide. When glass slides are scanned with a scanning instrument, a high-resolution digital image is produced that may be viewed on a computer screen or mobile device. The increasing adoption of digital pathology to improve lab efficiency, the rising prevalence of cancer, and the growing application of digital pathology in drug development and companion diagnostics, as well as the reduction of high costs associated with conventional diagnostics, are all contributing to the market’s growth. However, in the approaching years, a scarcity of qualified pathologists is projected to stifle market expansion for the period 2021-2026.
Report Coverage :
The report : “Digital Pathology Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Digital Pathology Market.
By Product : Scanner, Software, Communication Systems, and Storage system.
By Type : Human Pathology and Veterinary Pathology.
By Application: Drug Discovery, Disease Diagnosis, Teleconsultation, and Training & Education.
By End User : Pharmaceutical & Biotechnology Companies, Hospitals, and Reference Laboratories, and Academic & Research Institutes.
By Geography : North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa).